These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3671494)

  • 1. Compliance with long-term lithium treatment in major affective disorders.
    Danion JM; Neunreuther C; Krieger-Finance F; Imbs JL; Singer L
    Pharmacopsychiatry; 1987 Sep; 20(5):230-1. PubMed ID: 3671494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mortality in patients with affective disorder who commenced treatment with lithium. A 16-year follow-up].
    Brodersen A; Licht RW; Vestergaard P; Olesen AV; Mortensen PB
    Ugeskr Laeger; 2001 Nov; 163(46):6428-32. PubMed ID: 11816921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications of lithium plasma levels in professional practice. Average of a 7-year follow-up].
    Kessous-Adnet J; Mori M; Maillard M; Pascalis JG
    Ann Med Psychol (Paris); 1991 May; 149(5):429-33. PubMed ID: 1759736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guide to the long-term drug treatment of major affective disorder: a review.
    Cooper AJ
    Psychiatr J Univ Ott; 1988 Sep; 13(3):144-8. PubMed ID: 3054978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Compliance with and tolerance of sustained-release lithium carbonate].
    Lavantes B; Senimon F; Bayle FJ
    Encephale; 1999; 25(2):152-7. PubMed ID: 10370888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eight years follow-up of lithium prophylaxis in patients of psychiatric-neurological practice (author's transl)].
    Kurek M; Consbruch U
    Pharmacopsychiatria; 1982 Mar; 15(2):65-9. PubMed ID: 7079292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long term lithium treatment of affective disorders. Long term effects and side effects].
    Hofmann G; Grünberger J; König P; Presslich O; Wolf R
    Psychiatr Clin (Basel); 1974; 7(3):129-48. PubMed ID: 4464541
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bipolar patients in remission: personality disorders and changes in personality].
    Kröber HL
    Nervenarzt; 1993 May; 64(5):318-23. PubMed ID: 8321340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening and evaluation on predictive factors in lithium carbonate maintenance treatment of manic-depressive disorders].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Dec; 23(6):324-8, 383. PubMed ID: 1982995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence.
    Maarbjerg K; Aagaard J; Vestergaard P
    Pharmacopsychiatry; 1988 May; 21(3):121-5. PubMed ID: 3406049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
    Gonzalez-Pinto A; Mosquera F; Alonso M; López P; Ramírez F; Vieta E; Baldessarini RJ
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):618-24. PubMed ID: 17042834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of noncompliance on research in affective disorders.
    Frank E; Prien RF; Kupfer DJ; Alberts L
    Psychopharmacol Bull; 1985; 21(1):37-42. PubMed ID: 3983336
    [No Abstract]   [Full Text] [Related]  

  • 19. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder].
    Garcia-López A; Ezquiaga E; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2001; 29(5):327-32. PubMed ID: 11602090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.